Skip to navigation Skip to content


Master Page Does Not Exist


    Master Page Does Not Exist
    1. Arpeggio

      The purpose of this study is to find out whether treatment with the investigational drug laquinimod is safe and effective in reducing the loss of brain volume and MS worsening in patients with PPMS, along with assessing the safety of the drug and determining the side effects of different dosing levels.

      St. louis, MO 63110See Map
    2. A Trial of Vitamin D and Copaxone in Patients with Relapsing MS

      This research study will evaluate whether Vitamin D when given with Copaxone reduces the rate of relapse in 2 years. Eligible Participants will be randomized to receive either low dose or high dose vitamin D (oral) with Copaxone. Copaxone and Vitamin D are provided as part of the study.

      St. Louis, MO 63110See Map
    3. Children with Multiple Sclerosis

      Soe Mar, MD is conducting a research study to determine if risk factors identified for adult MS are also risk factors for pediatric MS, and if there are interactions between.

      St Louis, MO 63110See Map
    4. Donate Blood for Research

      Study to identify genes important in MS development (Dr. Laura Piccio and Dr. Anne Cross).

      st., MO 63110See Map
    5. Employment Study - VCU

      The Rehabilitation Research and Training Center (RRTC) at Virginia Commonwealth University (VCU) is conducting a study of adults with physical disabilities. We want to know about your barriers to employment as well as resources that you need to support your work / career goals. In addition, we are interested in knowing how you find information on employment services and supports.

    6. Job Accommodation Request Survey

      Individuals who are aged 55 or older and need job accommodations are being sought for a study by researchers at the Florida State University to share perceptions of factors related to accommodation requests by answering a few questions about yourself, your organization (if applicable), and your abilities and emotions in the process.

    7. MS Trial Alert: Investigators Recruiting People with Relapsing NMOSD for Study of an Investigational Medicine (Eculizumab)

      nvestigators are recruiting 132 people with Neuromyelitis Optica Spectrum Disorders (NMOSD) for a study comparing an experimental medicine with inactive placebo. There are currently no therapies that are approved for the treatment of NMOSD.

    8. Clinical Trial - ASCLEPIOS

      A randomized, double-blind, double-dummy, parallel-group study comparing the efficacy and safety of ofatumumab versus teriflunomide in patients with relapsing multiple sclerosis

      Chesterfield, MO 63017See Map
    9. Prevent

      The purpose of this study is to determine if eculizumab is safe and effective for preventing relapses in patients with relapsing NMO (Neuromyelitis Optica).

      St. Louis, MO 63110See Map
    10. The Refined Health Action Process Approach for Physical Activity Self-Regulation in People with MS

      University of Illinois researchers invite you to participate in a voluntary study of physical activity in people with Multiple Sclerosis.

    11. YourCareMoments

      Sign up with YourCareMoments and receive short, anonymous, online surveys about your healthcare experiences with MS or other health conditions. Each survey takes about 5-10 minutes and participants are paid per survey completion. This is an ongoing study.


    Master Page Does Not Exist
    1. Promising MS Research - Recorded Webcast

      Promising MS Research to Repair, Protect and Restore the Nervous System. Moderator Kate Milliken and panelists Dr. Ben Barres, Dr. Jonah Chan, Dr. Timothy Coetzee and Dr. Rhonda Voskuhl. December 5, 2013

    2. Clinical Trials in MS

      Large Phase 3 trials in RR MS. Updated September 2013. Abbreviations Key: AAN – American Academy of Neurology. CIS – Clinically Isolated Syndrome.

    3. Find Clinical Trials

      Clinical trials help to find solutions for everyone affected by MS. Find studies near you.

    4. From Clinical Trials to Treatments

      This presentation is: From Clinical Trials to Treatments.

    5. Symptomatic Treatment Trials

      This document outlines Symptomatic Treatment Trials.

    6. Emerging Therapies Collaborative

      The Multiple Sclerosis Emerging Therapies Collaborative has been organized to provide timely, evidence-based resources regarding the known benefits and risks of newly emerging, FDA-approved medications for MS. This group, which includes the MS Coalition, the American Academy of Neurology, the Multiple Sclerosis VA Centers of Excellence East and West, Can Do MS, Consortium of MS Centers, International Organization of MS Nurses, MS Association of America, MS Foundation, National MS Society, Unit

    7. MS Clinical Care Connection

      MS Clinical Care Connection - the Society's quarterly newsletter for healthcare professionals - delivers information and resources on a variety of clinical topics.

    8. MS Research Using Vision (OCT) Testing: Anti-LINGO-1 (video)

      Neuro-opthalmologist Tariq Bhatti, MD, at Duke University Eye Center, discusses the use of optical coherence tomography (OCT) in evaluating multiple sclerosis (MS) progression and the effects of treatments - namely anti-LINGO-1.


Master Page Does Not Exist
© 2024 The National Multiple Sclerosis Society is a tax exempt 501(c)3 nonprofit organization. Its Identification Number (EIN) is 13-5661935.